COURSE DESCRIPTION:

Please join us for a conference on Protecting the Airway:  Dysphagia and Aspiration Pneumonia in the Neuro ICU with Dr. Huimahn Alex Choi and speech language pathologist Kristin Abraham. This conference will explore evidence-based strategies for the prevention and treatment of aspiration pneumonia in critically ill neurological patients. The presentation will address clinical considerations for the timing of tracheostomy and percutaneous endoscopic gastrostomy (PEG) placement, as well as the role of pharyngeal electrical stimulation (PES) in dysphagia management and airway protection.

TARGET AUDIENCE:

Internal Medicine Physicians, Neurologists, Pharmacists, Physician Assistants, Residents, Advanced Practice Registered Nurses, Lab Personnel, Medical Students, and all other interested healthcare providers

LEARNING OBJECTIVES:

• Apply evidence-based strategies for the prevention and treatment of aspiration pneumonia.
• Evaluate clinical factors influencing the optimal timing of tracheostomy and percutaneous endoscopic gastrostomy (PEG) placement.
• Assess the role of pharyngeal electrical stimulation (PES) in the management of dysphagia and airway protection.

FACULTY AND DISCLOSURES:  
 

Huimahn Alex Choi, M.D., M.S.
Professor of Neurosurgery
McGovern Medical School at UTHealth
Director of Neurocritical Care
Memorial Hermann-Texas Medical Center 
Houston, Texas

Kristin Abraham, M.A. CCC-SLP
Rehab Services Coordinator
Speech-Language Pathologist
Memorial Hermann-Texas Medical Center
Houston, Texas 
 

Huimahn Alex Choi, M.D., M.S., faculty of this educational activity, is a consultant for Grace Therapeutics. He is an advisor for Aurenar. Dr. Choi owns stock and/or is a shareholder for Grace Therapeutics. He has indicated that the presentation or discussion will include off-label or unapproved product usage. All relevant financial relationships listed for this individual have been mitigated.

Kristin Abraham, M.A. CCC-SLP, faculty of this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will include off-label or unapproved product usage.

Ehizele Osehobo, M.D., MSc., director for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentations or discussions will include off-label or unapproved product usage.

Kendra Kent, MS, RN, CENP, CCRN, SCRN, CNRN, TCRN, planner for this educational event, has no relevant financial relationships with ineligible companies* to disclose.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies to disclose.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-1195520, by the Florida Boards of Medicine, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Occupational Therapists, Laboratory Personnel, Dietitians and Respiratory Therapists. Baptist Health South Florida CE Broker Provider #50-182.